Streetbeat News

Stock Prices

LSEA

Landsea Homes shares are trading lower following the release of their Q1 earnings, indicating a negative market reaction to the financial results.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 4:12 pm

ZBRA

UBS analyst Damian Karas has maintained a Buy rating on Zebra Technologies (NASDAQ:ZBRA) and increased the price target from $340 to $368, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 4:10 pm

KZIA

Kazia Therapeutics announced the completion of the EVT801 Phase 1 clinical trial, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 4:08 pm

LC

LendingClub shares are trading higher following the release of their better-than-expected Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 4:08 pm

HKD

AMTD Digital's stock price has increased following the announcement of its first half financial results.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 4:07 pm

MCD

PEP

SBUX

Starbucks Corporation (NASDAQ:SBUX) reported disappointing quarterly results with a decline in same-store sales and traffic, leading to a 12% drop in shares. The company lowered its fiscal 2024 forecast, expecting lower revenue growth and flat to low single-digit earnings growth. Despite the downturn, Starbucks is implementing a turnaround plan, including a new app for non-loyalty members, menu innovations, and significant supply chain cost savings.

Portfolio Pulse from Upwallstreet

May 01, 2024 | 4:07 pm

ACB

CGC

IMCC

TLRY

IM Cannabis Corp. (NASDAQ:IMCC) shares surged over 100% in the past five days, attributed to the DEA's plans to reschedule marijuana, boosting cannabis stocks. Despite the sector's overall drop, IMCC holds gains with heavy trading volume. The stock's year-to-date increase of 55.21% contrasts with its historical average annual return of -76.64%. The current RSI of 87.37 suggests overbought conditions.

Portfolio Pulse from Erica Kollmann

May 01, 2024 | 4:06 pm

HMST

HomeStreet shares are trading lower following the announcement of worse-than-expected Q1 GAAP EPS results.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 4:05 pm

AMGN

CTMX

CytomX Therapeutics, Inc. (NASDAQ:CTMX) shares surged following the announcement of its upcoming first-quarter results and an update on the CX-904 Phase 1a dose escalation study, developed in partnership with Amgen, Inc. (NASDAQ:AMGN). The update is scheduled for May 8, after market close. CTMX shares experienced heavy trading volume, significantly exceeding the 100-day average, and trading was temporarily halted due to a circuit breaker. The drug candidate CX-904 is in a Phase 1 study for advanced solid tumors.

Portfolio Pulse from Erica Kollmann

May 01, 2024 | 4:05 pm

JCI

Johnson Controls International Plc (NYSE:JCI) reported Q2 earnings with an EPS of 78 cents, surpassing expectations of 75 cents, but missed revenue forecasts with $6.699 billion against an expected $6.72 billion. Sales remained flat compared to the previous year, with a slight organic increase of 1%. The company took a $750 million pre-tax charge for a settlement related to its subsidiary's product. Organic orders grew by 12% year-over-year, and the Building Solutions North America segment saw a margin increase. The Q3 EPS outlook is slightly below estimates, but full-year EPS expectations are maintained. JCI shares dropped 6.65% to $60.73.

Portfolio Pulse from Nabaparna Bhattacharya

May 01, 2024 | 4:05 pm